Episode 20: Missing Data in Clinical Trials
from QCast: Data-Driven Dialogue in Drug Development Hosted by Quanticate
In this QCast episode, Jullia and Tom unpack missing data in clinical trials — why it biases effect estimates, how the estimand framework drives prevention and analysis choices, and what good sensitivity work and reporting look like for credible, inspection-ready results. Key Takeaways Define estimands and intercurrent-event strategies, then align follow-up and data collection. Prevent over correct with simpler schedules, remote options, continued follow-up, and early action on gaps. Use principled methods such as mixed models and multiple imputation, consider pattern-mixture approaches, avoid last observation carried forward. Demonstrate robustness through targeted sensitivity analyses, tipping-point checks, and clear summaries of missingness and reasons. 🔗 Learn More & Get Support: Visit quanticate.com to explore our biometrics services and discover how we can support your next clinical trial. 📝 Episode Notes & Transcript: Find show notes, resources, and a full transcript at quanticate.com/podcast. 🔔 Stay Connected: Subscribe to QCast on Apple Podcasts, Spotify, or your favourite platform to never miss an episode. About Quanticate Founded in 1994, Quanticate is a biometrics-focused CRO with over 30 years' experience delivering expert clinical and post-marketing data services worldwide. Specialising in the collection, management, standardisation, analysis, and reporting of data, we support pharma and biotech companies globally with high-quality solutions for clinical development. We specialise in: Clinical Data Capture & Management Biostatistics & Statistical Consultancy Statistical Programming & PK/PD Analysis Medical Writing & Pharmacovigilance Regulatory & Submission Support AI & Automation Post-Marketing Safety & Real-World Data Quanticate is committed to delivering expertise and solutions that drive the success of clinical development worldwide.
Embed this episode
What this episode covers
In this QCast episode, Jullia and Tom unpack missing data in clinical trials — why it biases effect estimates, how the estimand framework drives prevention and analysis choices, and what good sensitivity work and reporting look like for credible, inspection-ready results. Key Takeaways Define estimands and intercurrent-event strategies, then align follow-up and data collection. Prevent over correct with simpler schedules, remote options, continued follow-up, and early action ...
No transcript yet.